Nanox shares face pressure as a $40.7 million impairment charge and rising operating losses overshadow revenue growth, forcing the company to seek additional funding to bolster its $31.4 million cash balance.
Nanox reported a wider GAAP loss due to a large impairment charge, declining cash reserves, and ongoing dilution risk from planned fundraising.
Nanox reported a 37% revenue increase to $4.2 million for Q2 2026, yet faced a $55.5 million GAAP net loss driven by a $40.7 million impairment charge. Despite commercial progress in its imaging network and insurance reimbursement, the company's cash position dropped to $31.4 million, prompting management to signal further capital raises to sustain operations.
The loss was primarily driven by a $40.7 million non-cash impairment charge related to the company's AI solutions business, reflecting reduced revenue forecasts and share-price declines.
The company raised $8.5 million in gross proceeds following the quarter's end and stated its intention to continue raising capital from various sources while implementing cost-cutting measures, including a 67% workforce reduction in its South Korean operations.